Stride Ventures overshoots target to raise $200 mn for second fund
The firm was initially targeting to raise Rs 1000 crore for the second fund. A first close of Rs 500 crore was announced in August 2021.
Stay updated with breaking news from Accel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The firm was initially targeting to raise Rs 1000 crore for the second fund. A first close of Rs 500 crore was announced in August 2021.
Jify.co, in a release, said that it will use the funding "to strengthen its fintech product offering, ramp up customer acquisition across sectors and cities, while also driving adoption among the workforce."
ACCEL’s Ajyal Center recently became the first organization outside of the United States to be recognized with an NCASES accreditation for special education.
Cryo-Cell International (OTCMKTS:CCEL – Get Rating) and Marpai (NASDAQ:MRAI – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings. Insider and Institutional Ownership 10.7% of Cryo-Cell International shares are […]
Devo Technology has closed a new $100 million funding round that pushes its valuation in the $2 billion range.